ENHANCING IMMUNOGENICITY OF DNA VACCINES BY TARGETED DELIVERY TO ANTIGEN PRESENTING CELLS
Grant number: LP0883901 | Funding period: 2008 - 2009
Vaccines have proven to be one of the most effective means of preventing infection and also provide promise as a treatment for cancer. However, the range of effective technologies that make possible the delivery of vaccines that can protect against a broad range of infections is limited. DNA based vaccines are attractive because they are relatively easy to produce against a wide range of infections. However, DNA vaccines often provide poor protection against infections. This project will explore a unique technology developed in Australia and that will greatly improve the effectiveness of DNA vaccines against a broad range of diseases.